Display options
Share it on

Am J Pathol. 1987 Jun;127(3):549-58.

Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules.

The American journal of pathology

H M Shulman, A M Gown, D J Nugent

PMID: 2438942 PMCID: PMC1899766
Free PMC Article

Abstract

The authors immunostained autopsy liver tissue from 31 marrow transplant recipients, 19 with hepatic veno-occlusive disease (VOD) and 12 without VOD. A panel of monoclonal and polyclonal antibodies was used to characterize the materials within the occluded venous lesions and to define the location and types of injured cells. Most patients with early VOD (survival less than 50 days, n = 11) had dense periadventitial and intramural immunostaining of terminal hepatic and sublobular central venules (CV) with anti-Factor VIII (9/11) and anti-fibrinogen (4/4) but had no immunostaining with antibody to platelet GPIb. Early VOD patients also had marked loss of Zone 3 hepatocyte cytokeratin (8/9) versus late VOD (1/5) or non-VOD (2/7). Patients with late VOD lesions (n = 8, survival greater than 50 days) had increased collagen within occluded VOD lesions. Type III much greater than Type I, and increased sinusoidal collagens Types I, III, and IV. These studies and other data suggest the following events in the genesis of VOD. Initial injury to endothelium of CV and/or sinusoids and possibly also to Zone 3 hepatocytes triggers the coagulation cascade in the periadventitial zone of CV. The late sequela, collagenous CV occlusion, results from activated mural myofibroblasts and/or embolized Ito cells and hepatocytes.

Cited by

References

  1. Pathol Immunopathol Res. 1986;5(1):29-36 - PubMed
  2. Biochemistry. 1986 Sep 9;25(18):4979-83 - PubMed
  3. Am J Pathol. 1987 Jan;126(1):51-60 - PubMed
  4. Adv Exp Med Biol. 1976;75:497-503 - PubMed
  5. Blood. 1977 Apr;49(4):511-33 - PubMed
  6. Transplant Proc. 1977 Mar;9(1):181-5 - PubMed
  7. Cancer. 1979 Jan;43(1):174-81 - PubMed
  8. Arch Pathol Lab Med. 1980 Nov;104(11):584-8 - PubMed
  9. Gastroenterology. 1980 Dec;79(6):1178-91 - PubMed
  10. Cancer Res. 1981 Sep;41(9 Pt 1):3512-8 - PubMed
  11. Infect Immun. 1982 Oct;38(1):273-81 - PubMed
  12. J Cell Biol. 1982 Nov;95(2 Pt 1):414-24 - PubMed
  13. Anal Quant Cytol. 1982 Sep;4(3):188-98 - PubMed
  14. J Infect Dis. 1983 May;147(5):829-37 - PubMed
  15. Dig Dis Sci. 1983 Jul;28(7):651-66 - PubMed
  16. Hepatology. 1984 Jan-Feb;4(1):116-22 - PubMed
  17. Am J Pathol. 1984 Feb;114(2):309-21 - PubMed
  18. Int J Radiat Oncol Biol Phys. 1984 Jan;10(1):5-34 - PubMed
  19. Lab Invest. 1984 Aug;51(2):181-92 - PubMed
  20. Am J Pathol. 1984 Dec;117(3):418-28 - PubMed
  21. N Engl J Med. 1985 Jan 17;312(3):159-63 - PubMed
  22. Am J Pathol. 1985 Apr;119(1):158-67 - PubMed
  23. Nouv Rev Fr Hematol. 1985;27(1):27-8 - PubMed
  24. Transplantation. 1985 Jun;39(6):603-8 - PubMed
  25. Leuk Res. 1985;9(10):1255-61 - PubMed
  26. J Exp Med. 1986 Mar 1;163(3):740-5 - PubMed
  27. Hepatology. 1986 Mar-Apr;6(2):225-34 - PubMed
  28. J Exp Med. 1986 May 1;163(5):1260-6 - PubMed
  29. N Engl J Med. 1986 May 15;314(20):1298-304 - PubMed
  30. Blood. 1986 Jun;67(6):1773-6 - PubMed
  31. Int J Cell Cloning. 1986;4 Suppl 1:42-93 - PubMed
  32. Transplantation. 1986 Nov;42(5):497-501 - PubMed

Substances

MeSH terms

Publication Types

Grant support

LinkOut - more resources